{"name": "NKT Therapeutics",
 "permalink": "nkt-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/nkt-therapeutics",
 "homepage_url": "http://www.nktrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@nktrx.com",
 "phone_number": "617-454-1008",
 "description": "Biotherapeutics Developer",
 "created_at": "Sat Jun 20 07:19:02 UTC 2009",
 "updated_at": "Fri Oct 08 04:39:33 UTC 2010",
 "overview": "\u003Cp\u003ENKT Therapeutics is a privately held biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. The company\u0026#8217;s mission is to use its expertise to develop a pipeline of first-in-class NKT-based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma and dermatitis.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       20],
      "assets/images/resized/0004/9825/49825v1-max-150x150.jpg"],
     [[250,
       33],
      "assets/images/resized/0004/9825/49825v1-max-250x250.jpg"],
     [[450,
       60],
      "assets/images/resized/0004/9825/49825v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CMO",
    "person":
     {"first_name": "Barbara",
      "last_name": "Finck",
      "permalink": "barbara-finck",
      "image": null}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Michael",
      "last_name": "Ross",
      "permalink": "michael-ross-2",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-150x150.jpg"],
          [[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-250x250.jpg"],
          [[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$12M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.bizjournals.com/boston/stories/2009/03/16/daily8.html",
    "source_description": "NKT Therapeutics launches with $8M",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 3,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2010/08/23/daily23-NKT-Therapeutics-taps-backers-for-4M-in-new-round.html",
    "source_description": "NKT Therapeutics taps backers for $4M in new round",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 8,
    "funded_day": 25,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "233 Needham Street",
    "address2": "",
    "zip_code": "02464",
    "city": "Newton",
    "state_code": "ME",
    "country_code": "USA",
    "latitude": 42.3097378,
    "longitude": -71.214605}],
 "milestones":
  [{"description": "Names new Chief Medical Officer",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 5,
    "source_url": "http://www.masshightech.com/stories/2010/10/04/daily21-Finck-takes-top-medical-job-at-NKT-Therapeutics.html",
    "source_text": null,
    "source_description": "Finck takes top medical job at NKT Therapeutics",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "NKT Therapeutics",
      "permalink": "nkt-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        105],
       "assets/images/resized/0004/9826/49826v1-max-150x150.jpg"],
      [[250,
        176],
       "assets/images/resized/0004/9826/49826v1-max-250x250.jpg"],
      [[450,
        317],
       "assets/images/resized/0004/9826/49826v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}